Latest news
Strides Pharma Science Ltd (BOM:532531) (Q1 FY27) Earnings Call Highlights: Ex-US Growth Drives ... - Yahoo Finance UKYahoo Finance UK · Tue, 04 Aug 2026 01:04:00 GMTStrides Pharma Science Q1FY27 PAT surges 56.7% on Pivot Path gain - scanx.tradescanx.trade · Mon, 03 Aug 2026 07:00:00 GMTStrides Pharma Science Q4 Results: Earnings call audio available - scanx.tradescanx.trade · Sun, 02 Aug 2026 16:27:46 GMTStrides Pharma Science Q1 Results: Net profit rises 16% YoY to ₹2,113 lakh - scanx.tradescanx.trade · Sat, 01 Aug 2026 12:08:38 GMTStrides Pharma Science Ltd Revenue Breakdown – NSE:STAR - TradingViewTradingView · Sat, 01 Aug 2026 04:46:31 GMTStrides Pharma reports Rs. 1,265.4 crore revenue at 13% YoY growth in Q1 FY27 - Indian Pharma PostIndian Pharma Post · Fri, 31 Jul 2026 14:26:45 GMTStrides Pharma Science consolidated net profit rises 57.52% in the June 2026 quarter - Business StandardBusiness Standard · Fri, 31 Jul 2026 09:22:10 GMTStrides Pharma shares decline 5% after Q1; profit rises 58%, margins contract - CNBC TV18CNBC TV18 · Fri, 31 Jul 2026 08:36:56 GMT